Bacterial and Fungal Coinfections in COVID-19 Inpatients at a Tertiary Hospital in Surabaya, Indonesia, from November 2020 to February 2022
Downloads
Introduction: After the first discovery of coronavirus disease 2019 (COVID-19) in 2020, the rapid increase of cases beyond China prompted the declaration of a pandemic. Elevated rates of bacterial-fungal coinfection were observed in hospitalized COVID-19 patients. This study aimed to determine the profiles of bacterial and fungal coinfections in COVID-19 patients diagnosed between November 2020 and February 2022 at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Methods: This retrospective descriptive study obtained data from medical records and used total sampling to assemble 278 COVID-19 patients who met the inclusion criteria. The evaluated variables were subject characteristics, including age, sex, comorbidities, length of stay, ventilator use, bacterial coinfections, fungal coinfections, and bacterial-fungal coinfections.
Results: The age group of 55–64 years (26.9%) was predominant among the patients, with males (55.4%) outnumbering females. Hypertension was the most prevalent comorbidity (15.8%). The patients were mostly hospitalized for over ten days (66.2%). Eleven patients (4%) were admitted to the intensive care unit, and five patients (1.8%) required mechanical ventilation. The bacterial coinfections were primarily caused by Streptococcus viridans (56.6%), found in 145 sputum specimens, followed by Klebsiella pneumoniae (23.4%). The predominant isolates in the bacterial-fungal coinfections were Streptococcus viridans and Candida albicans (24.8%), identified in 125 sputum specimens, followed by Klebsiella pneumoniae and Candida albicans (18.4%).
Conclusion: COVID-19 patients with bacterial-fungal coinfections present certain characteristics, including being male, middle-aged, hypertensive, and hospitalized beyond ten days. Streptococcus viridans, Klebsiella pneumoniae, and Candida albicans are common etiologies in bacterial-fungal coinfections.
Highlights:
- This study overviews the distribution of patients and causative pathogens associated with bacterial, fungal, and bacterial-fungal coinfections, which have escalated with the rapid rise of coronavirus disease 2019 (COVID-19) hospitalization.
- Data on the causative pathogens of bacterial-fungal coinfection in COVID-19 patients can be considered in the development of guidelines for empirical therapy in clinical practice.
Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, et al. (2020). COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions? Journal of Fungi 6(4): 211. doi: 10.3390/jof6040211.
Asih D, Widodo A, Setiabudi R, Sulistiawati S, Tyasningsih W, et al. (2023). Biofilm formation by the interaction of fungi (Candida tropicalis) with various bacteria. Journal of Advanced Biotechnology and Experimental Therapeutics 6(1): 84. doi: 10.5455/jabet.2023.d108.
Asmarawati TP, Rosyid AN, Suryantoro SD, Mahdi BA, Windradi C, et al. (2021). The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya. F1000Research 10: 113. doi: 10.12688/f1000research.31645.2.
Bantun F (2023). Fungal–bacterial co-infections and super-infections among hospitalized COVID-19 patients: A systematic review. Journal of Fungi 9(6): 598. doi: 10.3390/jof9060598.
Bhardwaj P (2019). Types of sampling in research. Journal of the Practice of Cardiovascular Sciences 5(3): 157. doi: 10.4103/jpcs.jpcs_62_19.
Budayanti NS, Suryawan K, Iswari IS, Sukrama DM (2019). The quality of sputum specimens as a predictor of isolated bacteria from patients with lower respiratory tract infections at a tertiary referral hospital, Denpasar, Bali-Indonesia. Frontiers in Medicine 6. doi: 10.3389/fmed.2019.00064.
Butterworth M, McClellan B, Allansmith M (1967). Influence of sex on immunoglobulin levels. Nature 214(5094): 1224–1225. doi: 10.1038/2141224a0.
COVID-19 Task Force (2022). Situasi COVID-19 di Indonesia. Retrieved 16 December 2023, from https://infeksiemerging.kemkes.go.id/dashboard/covid-19.
COVID-19 Task Force of Surabaya City (2022). Surabaya Lawan COVID-19. Retrieved 16 December 2023, from https://lawancovid-19.surabaya.go.id/visualisasi/graph.
De Francesco MA, Signorini L, Piva S, Pellizzeri S, Fumarola B, et al. (2023). Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome. Journal of Medical Virology 95(7). doi: 10.1002/jmv.28892.
Franco DM, Masclans JR, Nuvials X, Gomez M, Enciso C, et al. (2022). The duration of mechanical ventilation is the main cause of bacterial/fungal superinfection in critically ill patients with COVID-19 at altitude. Journal of Experimental Pathology 3(2): 55–64. doi: 10.33696/pathology.3.040.
Hewagama A, Patel D, Yarlagadda S, Strickland FM, Richardson BC (2009). Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes & Immunity 10(5): 509–516. doi: 10.1038/gene.2009.12.
IBM Corp. Released 2015. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY. Retrieved from https://www.ibm.com/products/spss-statistics.
Ibrahim AM (2015). Uji efektivitas ekstrak daun sirih hijau (Piper betle Linn) terhadap pertumbuhan bakteri Streptococcus viridans dengan metode disc diffusion. UIN Syarif Hidayatullah Jakarta. Retrieved from http://repository.uinjkt.ac.id/dspace/handle/123456789/26340.
Jiang C, Li Z, Zhang L, Tian Y, Dong D, et al. (2016). Significance of hyphae formation in virulence of Candida tropicalis and transcriptomic analysis of hyphal cells. Microbiological Research 192: 65–72. doi: 10.1016/j.micres.2016.06.003.
Johnston KM, Lakzadeh P, Donato BMK, Szabo SM (2019). Methods of sample size calculation in descriptive retrospective burden of illness studies. BMC Medical Research Methodology 19(1): 9. doi: 10.1186/s12874-018-0657-9.
Khalil MAF, El-Ansary MRM, Bassyouni RH, Mahmoud EE, Ali IA, et al. (2022). Oropharyngeal candidiasis among Egyptian COVID-19 patients: Clinical characteristics, species identification, and antifungal susceptibility, with disease severity and fungal coinfection prediction models. Diagnostics 12(7): 1719. doi: 10.3390/diagnostics12071719.
Kokuina E, Breff-Fonseca MC, Villegas-Valverde CA, Mora-Díaz I (2019). Normal values of T, B and NK lymphocyte subpopulations in peripheral blood of healthy Cuban adults. MEDICC Review: International Journal of Cuban Health and Medicine 21(2–3): 16–21. Retrieved from https://www.scielosp.org/article/medicc/2019.v21n2-3/16-21/.
Lestari PE (2015). Peran faktor virulensi pada patogenesis infeksi Candida albicans. STOMATOGNATIC - Jurnal Kedokteran Gigi 7(2): 113–117. Retrieved from https://jurnal.unej.ac.id/index.php/STOMA/article/view/2064.
Maksimova EA, Kozlov AV, Lyamin AV, Zhestkov AV, Gusyakova OA, et al. (2022). Microflora of sputum and autopsy material of patients with COVID-19. Russian Clinical Laboratory Diagnostics 67(6): 380–384. doi: 10.51620/0869-2084-2022-67-6-380-384.
Morovati H, Eslami S, Farzaneh Bonab H, Kord M, Darabian S (2022). Bacterial and fungal coinfections among patients with COVID-19 in Zanjan, Northwest of Iran; a single-center observational with meta-analysis of the literature. Iranian Journal of Microbiology 14(5): 624–635. doi: 10.18502/ijm.v14i5.10955.
Nag VL, Kaur N (2021). Superinfections in COVID-19 patients: Role of antimicrobials. Dubai Medical Journal 4(2): 117–126. doi: 10.1159/000515067.
Negm EM, Mohamed MS, Rabie RA, Fouad WS, Beniamen A, et al. (2023). Fungal infection profile in critically ill COVID-19 patients: A prospective study at a large teaching hospital in a middle-income country. BMC Infectious Diseases 23(1): 246. doi: 10.1186/s12879-023-08226-8.
Novacescu AN, Buzzi B, Bedreag O, Papurica M, Rogobete AF, et al. (2022). Bacterial and fungal superinfections in COVID-19 patients hospitalized in an intensive care unit from Timișoara, Romania. Infection and Drug Resistance 15: 7001–7014. doi: 10.2147/IDR.S390681.
Orsini EM, Sacha GL, Han X, Wang X, Duggal A, et al. (2022). Risk factors associated with development of coinfection in critically Ill patients with COVID-19. Acute and Critical Care 37(3): 312–321. doi: 10.4266/acc.2022.00136.
Pemán J, Ruiz-Gaitán A, García-Vidal C, Salavert M, Ramírez P, et al. (2020). Fungal co-infection in COVID-19 patients: Should we be concerned? Revista Iberoamericana de Micología 37(2): 41–46. doi: 10.1016/j.riam.2020.07.001.
Rafat Z, Ramandi A, Khaki PA, Ansari S, Ghaderkhani S, et al. (2022). Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units. Gene Reports 27: 101588. doi: 10.1016/j.genrep.2022.101588.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, et al. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA 323(20): 2052. doi: 10.1001/jama.2020.6775.
Silva DL, Lima CM, Magalhães VCR, Baltazar LM, Peres NTA, et al. (2021). Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. Journal of Hospital Infection 113: 145–154. doi: 10.1016/j.jhin.2021.04.001.
Suh C, Do D (2022). The subsequent impact of COVID-19 for both immune dysregulation and opportunistic infections. Chest 162(4): A343. doi: 10.1016/j.chest.2022.08.265.
Wijaya D, Lasmaria R, Edra A (2022). Bacterial sputum culture results with moderate and severity COVID-19 patients in Pinere Room Arifin Achmad Hospital, Riau Province. In: Nusantara Science and Technology Proceedings. Galaxy Science. doi: 10.11594/nstp.2022.2816.
Yahya RO (2022). Problems associated with co-infection by multidrug-resistant Klebsiella pneumoniae in COVID-19 patients: A review. Healthcare 10(12): 2412. doi: 10.3390/healthcare10122412.
Yonge SA, Otieno MF, Sharma RR, Nteka SS (2019). Community normal reference values for CD3+, CD4+, CD8+T lymphocytes and leucocytes among immunocompetent adults in Coastal Kenya. Journal of Biosciences and Medicines 07(01): 99–114. doi: 10.4236/jbm.2019.71009.
Zago CE, Silva S, Sanitá PV, Barbugli PA, Dias CMI, et al. (2015). Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA). PLOS ONE 10(4): e0123206. doi: 10.1371/journal.pone.0123206.
Zhang H, Zhang Y, Wu J, Li Y, Zhou X, et al. (2020). Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerging Microbes & Infections 9(1): 1958–1964. doi: 10.1080/22221751.2020.1812437.
Zhou F, Yu T, Du R, Fan G, Liu Y, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet 395(10229): 1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
Copyright (c) 2025 Naura Ghina Shabira, Agung Dwi Wahyu Widodo, Musofa Rusli
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
